|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Saturday
Merck's Vioxx Heir - Forbes.com:
"Merck has released the first data from a giant study of Arcoxia, the drug that was designed to be an heir to its withdrawn painkiller Vioxx, and says it still hopes the U.S. Food and Drug Administration will approve the drug, based on the new data..Merck says the study found no more risk to the heart from Arcoxia than with an older drug that is commonly used in Europe. But, as Forbes.com predicted on Monday, critics still see problems with data. ...." |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||